CB

Culture Biosciences

www.culturebiosciences.com link_icon
browser_icon
Website www.culturebiosciences.com
lightning_bolt Market Research

Culture Biosciences Market Research Report



Company Overview



  • Name: Culture Biosciences

  • Mission: To create a world where bioprocess is never the bottleneck.

  • Founded by: No information is available

  • Key People:

  • Darcy Birse - Chief Executive Officer

  • Sumeet Agrawal - VP of Strategy and Finance

  • Lisa Krallis - VP Commercial

  • Babu Sivaraman - VP of Product and R&D

  • Lauren Kellogg - VP of Corporate Development

  • Palmer Lam - VP of Operations

  • Headquarters: San Francisco, California, USA

  • Number of Employees: No information is available

  • Revenue: No information is available

  • What is the company known for: Culture Biosciences is known for its cloud-connected bioreactors that enable cell culture experiments with more flexibility, providing fast and accurate answers to critical bioprocess questions.


Products



Cloud-Connected Bioreactors


  • Overview:

  • 250mL bench-scale single-use bioreactor

  • 5L single-use bioreactor

  • Key Features:

  • Real-time process data monitoring

  • Flexible, modular design for scaling

  • Designed for multiple applications: mammalian, microbial, viral vector, and media development


Software: ConsoleTM


  • Overview: A secure web application for real-time experiment design, monitoring, and data analysis.

  • Key Features:

  • One interface for all experiments

  • Remote access and collaboration capabilities

  • Analytics tools and real-time monitoring

  • Data science support for design of experiments (DOE)


Solutions



Culture as a Service


  • Description: Bioprocess development executed in Culture’s cloud-connected labs.

  • Benefits:

  • Access hundreds of bioreactors without capital expenditure

  • Real-time monitoring and data analytics

  • Flexible capacity to meet experimental demands


Applications


  • Protein Therapeutics:

  • Accelerates process development, characterization, and material generation.

  • Supports cell lines like CHO and HEK for protein production.

  • Viral Vectors:

  • Optimizes upstream process development and minimizes bottlenecks.

  • Effective for various viral genome titer, capsid titer analyses, etc.

  • Synthetic Biology:

  • Facilitates strain screening and fermentation process optimization.

  • Experienced in over 2,000 microbial strains and conducted over 20,000 successful runs.


Recent Developments



New Products/Features


  • 5L Single-Use Bioreactor: Launched to address customer needs for larger process development and material generation.

  • Cloud-Connected Platform: Continuous updates to software for refined user experience in design, monitoring and analysis of experiments.


Partnerships


  • Collaboration with Cytiva: Partnership to ensure predictable performance from Culture’s ecosystem to higher scales of clinical or commercial production.


Research and Publications


  • White papers and Case Studies:

  • "Scaling up HEK cell culture process from 250mL to 5L bioreactor"

  • "High-throughput Screening of Next-Gen Small Molecule Enhancers"

  • "AAV Process Development in Culture Biosciences’ 250mL Bioreactors"


Industry Recognition


  • Customer Testimonials:

  • Positive feedback from industry leaders like Modern Meadow, Kalion, Zymergen, and Every.

  • "Culture feels like an extension of our own fermentation lab, not like a CRO." - Shashway Vajpeyi, Modern Meadow

  • "Culture really excels at their data platform. I haven't seen anything like it before." - Charles Tindell, Every


Service Packages


  • Clone, Strain & Construct Screening

  • Evaluate clones, strains, and viral constructs with seamless scale-out.

  • Process Development

  • Media screening and optimization experiments for process improvement.

  • Process Characterization

  • Characterize processes in scale-down bioreactors to fine-tune parameters.

  • Process Model Development

  • Develop in-silico models (Digital Twins) for process predictability.

  • Scale-Out Capacity

  • Utilize bioreactor capacity to meet rapid, overflow experimental needs.


Facility and Capabilities


  • Laboratories: Located in San Francisco, featuring state-of-the-art bioreactors and analytical instrumentation.

  • Bioreactors:

  • >300 bioreactors available for various scales and process requirements.

  • Compliance with stringent quality and safety standards (BSL-2, SOC2).


Analytics Capabilities


  • Microbial Bioprocess: Biomass quantification, Metabolite analysis

  • Mammalian Bioprocess: Viability and cell counts, Metabolite analysis, Host cell protein

  • Viral Vector Analysis: Capsid titer, Viral genome titer, Empty/full ratio


No additional commentary is necessary. The data included is from the information provided.
Browse SuperAGI Directories
agi_contact_icon
People Search
agi_company_icon
Company Search
AGI Platform For Work Accelerate business growth, improve customer experience & dramatically increase productivity with Agentic AI